Uber and Chinese autonomous vehicle company WeRide have launched robotaxi operations without a human safety operator in Dubai as part of a broader expansion in the Middle East.Riders can now book the vehicles through Uber’s app, with operations in commercial and industrial districts like Dubai Silicon Oasis, Dubai Investment Park Second, and Jabal Ali Industrial First, as well as suburban areas and the maritime trading hub Al Hamriya Port. The service is operated locally by Tawasul, a mobility and fleet ope ...

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e., buying assets at a discount, e.g., net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e., buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get st ...

U.S. real estate stocks have had a choppy month, with the sector pressured by higher mortgage rates, which kept borrowing costs elevated and weighed on property valuations. Below is a list of ten real estate stocks ranked by their one-month ...

It's only when markets are choppy that investors find out what their real risk tolerance is. It's easy to fill out a questionnaire and say you'd be able to withstand a correction or bear market, but it's another thing entirely to actually see 10%, 20%, or more of your portfolio wiped out -- often more quickly than you'd expect. If you're finding that you're less tolerant of risk than you expected in the downturn over the past month, then the concept of an "all-weather portfolio" might appeal to you. One ...

Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, marking a significant expansion of the drugmaker's neuroscience portfolio into sleep medicine. Under th... ...

The company’s business model centers on the discovery, development, and commercialization of innovative medicines for rare hematologic diseases.Agios Pharmaceuticals develops and commercializes therapeutics targeting cellular metabolism, with its lead product, PYRUKYND (mitapivat), for hemolytic anemias, and AG-946 in Phase I clinical trials.How does this trade relate to historical activity? Krishnan joined Agios on March 5, 2025, making this transaction his one-year employment anniversary and the first ves ...

Banco de Chile ( BCH ) has a forward non-GAAP price-to-earnings multiple of 13.39x, which represents excellent value compared to Banco Santander-Chile's and Bradesco's multiples of 11.59x and 6.95x, respectively. BCH also benefits from being the leading bank in Chile's concentrated bankingI'm DCF Value Investor a passionate individual analyst with unique ideas that cover all types of stocks and commodities. I focus on companies fundamentals and valuation, to deliver a proper investment analysis. My ideas ex ...

Stablecoins are changing hands more than ever, with the market looking set to grow five times over to be worth $2 trillion by 2028, according to new research from British bank Standard Chartered. The new report also notes that stablecoins have found more use cases, which has drummed up velocity, the rate the digital tokens are turned over. “Overall stablecoin velocity has doubled over the past two years, with stablecoins now turning over six times a month on average,” the report authored by Geoff Kendri ...

Philadelphia, Pennsylvania--(Newsfile Corp. - March 31, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo" or the "Company") on behalf of investors who purchased Mereo American Depositary Shares (ADS) during the period from June 5, 2023 through December 26, 2025 (the "Class Period").Investor Deadline: Investors who purchased Mereo securities during the Class Period may, no later than April ...